(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
Cancer Serviks
1. Copyright http://www.ilmukedokteran.net
HPV dan kanker serviks
Dr. Toto Imam Soeparmono, SpOG, K. Onk
Subbag Ginekologi Onkologi
Dep Obgin RSPAD Gatot Soebroto
Jakarta
Copyright http://www.ilmukedokteran.net
2. Copyright http://www.ilmukedokteran.net
Nama :
Dr. Toto Imam Soeparmono, SpOG, K.Onk
Pangkat : Letkol CKM / Nrp 31418
Jabatan : Kasub Instal Rawat Inap B
Jabatan lain :1. Kadep obgin RSPAD
2. Ka Komite Penanggulangan
Kanker terpadu RSPAD
3. Konsultan Kanker
Kandungan
Copyright http://www.ilmukedokteran.net
3. Copyright http://www.ilmukedokteran.net
Umur : 48 thn
Status : K4
Dik Umum :1. Dokter umum (FK
Unair 1987)
2. SpOG (FK Unsri 1997)
3. Konsultan Kanker Kan-
dungan (FK UI 2005)
Dik Militer :1. PDAD (1987)
2. Selapa Kes (2006)
Copyright http://www.ilmukedokteran.net
9. Copyright http://www.ilmukedokteran.net
Why?
Cervical cancer is a significant public health problem
in many countries.
Cervical cancer is a sexually transmitted disease.
Cervical cancer is preventable (i.e., Methods of
screening and treatment for precancerous lesions
exist).
Pap Smear as a screening methods may not be
appropriate or adequate for many low-resource
settings.
Copyright http://www.ilmukedokteran.net
10. Copyright http://www.ilmukedokteran.net
Cervical cancer is one of the most
common cancers, accounting for 6%
of all malignancies in women. There
are an estimated 16,000 new cases of
invasive cancer of the cervix and
5,000 deaths in the U.S each year
Copyright http://www.ilmukedokteran.net
11. Copyright http://www.ilmukedokteran.net
•Number 1 fatal cancer in women
internationally.
•More than 400,000 new diagnoses
each year
•More than 200,000 deaths
(80% in developing countries)*
*Reproductive Health Online, 2004. Available: http://www.rho.org
Copyright http://www.ilmukedokteran.net
12. Copyright http://www.ilmukedokteran.net
5th most common cancer in humans
2nd most common cancer in women
1st most common woman cancer in INA
Relatively early age of death
median of 57 years versus 72 years for other
cancers
Great loss of productive years of life for
each case
Copyright http://www.ilmukedokteran.net
13. Copyright http://www.ilmukedokteran.net
Ranking of global female cancer incidence and
mortality by site, 2002
Site Incidence Proportion (%)
Mortality
1 Breast 1,151,298 410,712 0.36
2 Cervix uteri 493,243 273,505 0.55
3 Colon/rectum 472,687 250,532 0.53
4 Lung 386,891 330,786 0.85
5 Stomach 330,518 254,297 0.77
6 Ovary 204,499 124,860 0.61
7 Corpus uteri 198,783 50,327 0.25
8 Liver 184,043 181,439 0.98
Parkin DM, et al.Global Cancer Statistic, 2002
Copyright http://www.ilmukedokteran.net
14. Copyright http://www.ilmukedokteran.net
Ranking of cancer incidence by site in Indonesia,
1998
Site Number Proportion of total (%)
1 Cervix uteri 3686 17.85
2 Breast 2617 12.67
3 Skin 1270 6.15
4 Nasopharynx 1137 5,51
5 Rectum 1051 5.09
6 Ovary 1048 5.08
7 Lymphoma 926 4.48
8 Colon 653 3.16
Mangunkusumo R, 2005), Pidato Pengukuhan
Copyright http://www.ilmukedokteran.net
15. Copyright http://www.ilmukedokteran.net
1. Cervical Ca still a leading type of Ca among the
woman
2. Ca Cervix represent 11 % of total cancer in woman
and 66 % of gynecology Cancer
3. Overall survival rate cervical cancer in INA is low
4. Patients come to hosp. in the late stages
5. Death can prevent only by screening routinely
6. Adeno Ca of the cervix is increasing
7. Developing of the early detection and
the management of the cervical cancer is
important
Copyright http://www.ilmukedokteran.net
17. Copyright http://www.ilmukedokteran.net
Cervical Cancer
NATURAL HYSTORY
PRA -CANCER CANCER
15 % 30 % 45 %
MILD MODERATE SEVERE
NORMAL DYSPLASIA DYSPLASIA DYSPLASIA CANCER CANCER
IN CITU INVASIVE
40 % 20 %
Low Grade SIL High Grade SIL
SCREENING
Copyright http://www.ilmukedokteran.net
19. Copyright http://www.ilmukedokteran.net
STAGE. I
CONFINED TO UTERUS (EXTENSION TO CORPUS SHOULD
BE DISREGARDED.
STAGE. Ia. – DIAGNOSED ONLY BY MICROSCOPY
STAGE. Ia.1 : - STROMAL INVASION </= 3
mm
- HORIZONTAL SPREAD </= 7 mm
STAGE. Ia.2 : - STROMAL INVASION >3 mm - </= 5 mm
- HORIZONTAL SPREAD </= 7mm
Copyright http://www.ilmukedokteran.net
20. Copyright http://www.ilmukedokteran.net
STAGE. Ib.
CLINICALLY VISIBLE LESION CONFINED TO
THE CERVIX OR MICROSCOPIC
LESION GREATER THAN STAGE Ia.1.
STAGE. Ib.1 : - GREATEST DIMENSION </= 4
cm.
STAGE. Ib.2 : - GREATEST DIMENSION > 4
cm.
Copyright http://www.ilmukedokteran.net
22. Copyright http://www.ilmukedokteran.net
STAGE. II
TUMOR INVADES BEYOND THE
UTERUS BUT NOT TO PELVIC WALL
OR TO LOWER THIRD OF THE
VAGINA.
STAGE. IIa.
= WITHOUT PARAMETRIAL
INVASION
STAGE. IIb.
= WITH PARAMETRIAL INVASION
Copyright http://www.ilmukedokteran.net
24. Copyright http://www.ilmukedokteran.net
STAGE. III
TUMOR EXTENDS TO PELVIC WALL AND/OR
INVOLVES LOWER THIRD OF THE VAGINA
STAGE. IIIa.
= INVOLVES LOWER THIRD OF VAGINA NO
EXTENSION TO PELVIC WALL.
STAGE. IIIb.
= TUMOR EXTENDS TO PELVIC WALL
AND/OR
CAUSES HYDRONEPHROSIS OR NON-
FUNCTIONING KIDNEY.
Copyright http://www.ilmukedokteran.net
28. Copyright http://www.ilmukedokteran.net
HPV Infection
High number of sexual partners
Low social economic status
Smoking
History of STDs
Any combination of the above
Copyright http://www.ilmukedokteran.net
29. Copyright http://www.ilmukedokteran.net
Pada tahap prakanker sering tidak
menimbulkan gejala sama sekali (92%)
kecuali ada infeksi: keputihan
Kalau sudah timbul gejala biasanya kanker
sudah bertumbuh
Copyright http://www.ilmukedokteran.net
30. Copyright http://www.ilmukedokteran.net
Perdarahan pasca senggama
Keputihan
Gangguan lain akibat kanker sudah lanjut:
nyeri pinggul
gangguan BAB
gangguan BAK
BB menurun
lemah atau kurang darah akibat perdarahan
Copyright http://www.ilmukedokteran.net
31. Copyright http://www.ilmukedokteran.net
Treatment modalities based on stage
Side effects and toxicities of whole pelvic
radiation and brachytherapy with
chemotherapy
Sexual side effects of different treatment
Vaginal shortening
Vaginal coaptation with radiation therapy
Radiation necrosis
Loss of ovarian function
Decreased lubrication
Copyright http://www.ilmukedokteran.net
35. Copyright http://www.ilmukedokteran.net
Menganut terapi lesi pra kanker
(Konisasi, LEEP, LETZ, Laser)
Untuk usia tua, jumlah anak cukup dilakukan
sampel histerektomi (tipe I)
Follow up
Copyright http://www.ilmukedokteran.net
36. Copyright http://www.ilmukedokteran.net
Pada beberapa keadaan dapat dilakukan konisasi
(Coppleson, 1992, Ostor, Roman)
Ekstra Facial Histerektomi
Follow up
Copyright http://www.ilmukedokteran.net
40. Copyright http://www.ilmukedokteran.net
Beberapa kasus kanker serviks stadium II B,
dapat diberikan neo-ajuvan khemoradiasi atau
khemoterapi, kemudian dilakukan histerektomi
radikal.
Hal ini akan menambah 5 YSR.
Copyright http://www.ilmukedokteran.net
41. Copyright http://www.ilmukedokteran.net
Status dari kelenjar getah bening
Besar ukuran tumor primer
Kedalaman invasi stroma
Ada atau tidaknya invasi ke dalam pembuluh
darah atau limfe
Jenis histopatologi dari sel kanker
Bebas atau tidaknya tepi vagina
Copyright http://www.ilmukedokteran.net
45. Copyright http://www.ilmukedokteran.net
P. V. B.
Paclitaxel + Carboplatin
Cisplatin + Hidroxyurea + 5 FU
Kombinasi – kombinasi yang lain
Copyright http://www.ilmukedokteran.net
48. Copyright http://www.ilmukedokteran.net
Pada Kulit
Pada saluran cerna (mual, muntah, diare,
rektal bleeding, proctitis karena radiasi)
Pada saluran kencing (hematuria)
Copyright http://www.ilmukedokteran.net
49. Copyright http://www.ilmukedokteran.net
Komplikasi & Efek samping
Khemoterapi
1. Sistim Hemopoetik :
* Pansitopeni.
2. Sistim Gastrointestinal :
* Mual muntah, diare.
* Stomatitis.
* Perdarahan saluran cerna.
* Enterocolitis.
3. Immunosupressi.
4. Pada kulit :
* Reaksi alergi, iritasi, sampai Steven Johnson
Syndrome.
* Alopecia.
5. Pada Hati :
* Drug induced hepatitis.
Copyright http://www.ilmukedokteran.net
50. Copyright http://www.ilmukedokteran.net
6. Pada Paru-paru :
* Interstitial pneumonitis.
7. Pada Jantung :
* Kardiomiopati.
8. Pada Saluran Kencing :
* Chronic azotemia
* Acute renal failure
* Retensi cairan.
9. Pada Sistim Saraf :
* Neuropati.
10. Pada Pembuluh Darah :
* Kerusakan pembuluh darah.
Copyright http://www.ilmukedokteran.net
52. Copyright http://www.ilmukedokteran.net
Tujuan :
Untuk mengetahui hasil yang segera dari
pengobatan
Untuk mengidentifikasi komplikasi dari
pengobatan
Untuk mendeteksi penyakit yang resisten atau
rekuren
Copyright http://www.ilmukedokteran.net
53. Copyright http://www.ilmukedokteran.net
Tahun I - II Setiap 3 bulan
Tahun III – V Setiap 6 bulan
Lebih dari 5 tahun Setiap tahun
Copyright http://www.ilmukedokteran.net
54. Copyright http://www.ilmukedokteran.net
FIGO Stage % Cases 5-Year Survival
I 46% 83%
II 28% 64%
III 21% 38%
IV 4% 14%
FIGO Annual Report. J Epi & Biostat 1998;
3(1)
Copyright http://www.ilmukedokteran.net
57. Copyright http://www.ilmukedokteran.net
Double stranded virus, famili Papopa virus
Genome sirkuler 7- 8 kilo base-pairs (kbp)
dibungkus kapsid berbentuk icosahedral
Untaian nukleotidenya :
early region ( E1,2,4,5,6,7)
late region ( L1,2)
Copyright http://www.ilmukedokteran.net
58. Copyright http://www.ilmukedokteran.net
Virion, Genome DNA:
double-stranded
circular
8000 base pair
Capsid:
a naked icosahedral
55 nm in diameter
Copyright http://www.ilmukedokteran.net
59. Copyright http://www.ilmukedokteran.net
Genome virus mempunyai 8 gen (ORFs =
open reading frames):
E (early)1, E2, E4, E5, E6, E7 serta L (late)1 dan
L2
Absolutely tissue spesific
Target infeksi: basal keratinocytes
Ekspresi protein virus pada upper layer
Copyright http://www.ilmukedokteran.net
61. Copyright http://www.ilmukedokteran.net
Regulation of Viral
transcription & replication
Growth
E2
Stimulation
E5 E4
Encodes for
E1
minor capsid
protein Regulation of viral
L2
replication
HPV
genome
(-7815 base pairs)
Encodes for
E7
major capsid Transforming genes/
protein growth stimulation
L1
Late gene E6
URR
( Upper regulatory regions )
Gambaran Skematik dari organisasi genome HPV
Copyright http://www.ilmukedokteran.net
63. Copyright http://www.ilmukedokteran.net
120 genotypes berbeda
tergantung sekuens DNA pada gen L1 yang meng-
kode major capsid protein
30 tipe hidup pada mukosa anogenital
ada subtype dan varian
Terbagi menjadi:
cutaneous types
mucosotropic types
Copyright http://www.ilmukedokteran.net
64. Copyright http://www.ilmukedokteran.net
Group Prototyp Site Acute Chronic
e disease disease
Cutan. 1,2 Skin Warts None
Cutan-HR 5, 8 Skin Flat SCC
lesions
or Warts
Mucos-LR 6, 11 Anogenital Warts None
mucosa
Mucos-HR 16, 18, Anogenital Flat SCC
31, 33, 45 mucosa, lesions
oral
mucosa
Copyright http://www.ilmukedokteran.net
65. Copyright http://www.ilmukedokteran.net
Nonenveloped double-
stranded DNA virus1
>120 types identified2
~30–40 anogenital types2,3
~15–20 oncogenic types*,2,3
HPV 16 and HPV 18 types
account for the majority of
worldwide cervical cancers.4
~15-20 nononcogenic**
types
HPV 6 and 11 types are most
often associated with
external anogenital
warts.3
*High risk; ** Low risk
1. Howley PM, Lowy DR. In: Knipe DM, Howley PM, eds. Philadelphia, Pa: Lippincott-Raven; 2001:2197–2229.
2. Schiffman M, Castle PE. Arch Pathol Lab Med. 2003;127:930–934. 3. Wiley DJ, Douglas J, Beutner K, et al. Clin Infect Dis. 2002;35(suppl 2):S210–S224. 4.
Muñoz N, Bosch FX, Castellsagué X, et al. Int J Cancer. 2004;111:278–285.
Copyright http://www.ilmukedokteran.net
66. Copyright http://www.ilmukedokteran.net
14.6
HPV Type
16
18
69.7
45
25.7
31
North America/
Europe 17 33
52.5
52
67.6 58
South Asia
12.6 Others
Northern Africa
57
Central/South Indonesia: 16 = 43,7 %
America 18 = 39,4 %
*A pooled analysis and multicenter case control study (N = 3607)
1. Muñoz N, Bosch FX, Castellsagué X, et al. Int J Cancer. 2004;111:278–285.
Copyright http://www.ilmukedokteran.net
67. Copyright http://www.ilmukedokteran.net
Natural HPV Disease Progression
Definitive
Efficacy
0 to 1 Year 0 to 5 Years Up to 20 Years
Persistent CIN Cervical
Infection 2/3 Cancer
Initial or
HPV AIS
Infx
CIN 1
Cleared HPV Infection
Copyright http://www.ilmukedokteran.net
68. Copyright http://www.ilmukedokteran.net
High Risk types :
16, 18,
31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82
Probable high risk types :
26, 53, and 66
Low risk type :
6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81, and CP6108
(Munos et al, N Engl J Med 2003; 348:518-27)
Copyright http://www.ilmukedokteran.net
72. Copyright http://www.ilmukedokteran.net
Abstinence and lifetime mutual monogamy
risk avoidance Vs. risk reduction
Condoms offer little protection from infection
but may reduce the likelihood of developing
warts or cancer
Prophylactic vaccines offer strong promise for
prevention in the future
Copyright http://www.ilmukedokteran.net
73. Copyright http://www.ilmukedokteran.net
Mucosotropic HPV virions tetap tinggal pd
lokasi infeksi awal dan tidak memicu lisis sel
Dg terjadinya replikasi normal sel, antigenic
capsid protein tdk diekspresikan sampai sel
berdifferensiasi menjadi lapisan superfisial
Sel yg terinfeksi HPV resisten thd NK cells
tapi dpt dilisis oleh cytokine-activated NK
cells dan macrophage perlu waktu untuk
membersihkan infeksi dg sistem immune
Copyright http://www.ilmukedokteran.net
74. Copyright http://www.ilmukedokteran.net
Innate response terjadi segera, seroconversi menjadi
antibodi thd HR-HPV bisa perlu waktu 6 bln sampai
1 tahun. Seroconversi untuk tipe LR hampir
bersamaan dg saat infeksi
Antibodi thd protein capsid bisa bertahan sampai 10
– 15 tahun
Ab penting untuk mencegah infeksi dan re-infeksi
Strong cell-mediated response penting untuk viral
clearance ( mell APC, T helper cells, cytolitic T cells
dan costimulatory cytokines)
Copyright http://www.ilmukedokteran.net
75. Copyright http://www.ilmukedokteran.net
HPV sangat resistent terhadap panas dan
proses pengeringan (desiccation).1
Transmisi non seksual melalui penggunaan
alat-lat pribadi dapat juga terjadi, seperti
penggunaan bersama handuk, pakaian yang
telah terkontaminasi. 1
Kebanyakan infeksi HPV bisa bertahan
selama 8 bulan dan kemudian menghilang.
Namun sesudah 2 tahun, ditemukan sekitar
10% wanita masih membawa virus yang aktif
dalam vagina dan serviks2
1.Roden RJ Infect Dis 1997;176:1076-9;2.McIntosh N JHPIEGO Str Papers 2000;8:1-14;
Copyright http://www.ilmukedokteran.net
77. Copyright http://www.ilmukedokteran.net
PENCEGAHAN DETEKSI DINI PENGOBATAN
EDUKASI PAP SMEAR Kemoterapi
Radioterapi
KONDOM VIA Pembedahan
VAKSINASI atau
Konsultasi
kepada dokter
anda
Copyright http://www.ilmukedokteran.net
83. Copyright http://www.ilmukedokteran.net
Cancer cx is still a disease with high
insidence mortality and costly
Primary and secondary prevention can
reduce incidence and cancer death
Vaccine is an alternative in developing
country that can not run and organized
screening properly
Copyright http://www.ilmukedokteran.net
84. Copyright http://www.ilmukedokteran.net
Hindari penyebab Hindari faktor
resiko
Deteksi dini
VAKSINASI dg test Pap
Jangan takut dengan perkataan KANKER
Timbulkan keyakinan, bila ditemukan lebih dini,
penyakit dapat disembuhkan
Copyright http://www.ilmukedokteran.net